Zhou Cuiyan, Shang Wangsong, Yin Shan-Kai, Shi Haibo, Ying Weihai
School of Biomedical Engineering and Med-X Research Institute, Shanghai Jiao Tong University, Shanghai, China.
Department of Otorhinolaryngology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University, Shanghai, China.
Front Mol Biosci. 2021 Jul 26;8:655687. doi: 10.3389/fmolb.2021.655687. eCollection 2021.
Neuroinflammation is a key pathological factor in numerous neurological disorders. Cumulating evidence has indicated critical roles of NAD/NADH metabolism in multiple major diseases, while the role of malate-aspartate shuttle (MAS) - a major NADH shuttle - in inflammation has remained unclear. In this study we investigated the roles of MAS in LPS-induced neuroinflammation both and . Immunofluorescence staining, Western blot assay and Real-time PCR assays were conducted to determine the activation of Iba-1, the protein levels of iNOS and COX2 and the mRNA levels of IL-1β, IL-6, and TNF-α , showing that both pre-treatment and post-treatment of aminooxyacetic acid (AOAA) - an MAS inhibitor - profoundly decreased the LPS-induced neuroinflammation in mice. BV2 microglia was also used as a cellular model to investigate the mechanisms of this finding, in which such assays as Western blot assay and nitrite assay. Our study further indicated that AOAA produced its effects on LPS-induced microglial activation by its effects on MAS: Pyruvate treatment reversed the effects of AOAA on the cytosolic NAD/NADH ratio, which also restored the LPS-induced activation of the AOAA-treated microglia. Moreover, the lactate dehydrogenase (LDH) inhibitor GSK2837808A blocked the effects of pyruvate on the AOAA-produced decreases in both the cytosolic NAD/NADH ratio and LPS-induced microglial activation. Our study has further suggested that AOAA produced inhibition of LPS-induced microglial activation at least partially by decreasing STAT3 phosphorylation. Collectively, our findings have indicated AOAA as a new and effective drug for inhibiting LPS-induced neuroinflammation. Our study has also indicated that MAS is a novel mediator of LPS-induced neuroinflammation due to its capacity to modulate LPS-induced STAT3 phosphorylation, which has further highlighted a critical role of NAD/NADH metabolism in inflammation.
神经炎症是众多神经系统疾病的关键病理因素。越来越多的证据表明,NAD/NADH代谢在多种重大疾病中起着关键作用,而苹果酸-天冬氨酸穿梭(MAS)——一种主要的NADH穿梭机制——在炎症中的作用仍不清楚。在本研究中,我们从体内和体外两方面研究了MAS在脂多糖(LPS)诱导的神经炎症中的作用。通过免疫荧光染色、蛋白质印迹分析和实时聚合酶链反应分析来确定离子钙结合衔接分子1(Iba-1)的激活情况、诱导型一氧化氮合酶(iNOS)和环氧化酶2(COX2)的蛋白水平以及白细胞介素-1β(IL-1β)、白细胞介素-6(IL-6)和肿瘤坏死因子-α(TNF-α)的mRNA水平,结果表明,MAS抑制剂氨基氧乙酸(AOAA)的预处理和后处理均能显著降低LPS诱导的小鼠神经炎症。BV2小胶质细胞也被用作细胞模型来研究这一发现的机制,采用了蛋白质印迹分析和亚硝酸盐分析等检测方法。我们的研究进一步表明,AOAA通过对MAS的作用对LPS诱导的小胶质细胞激活产生影响:丙酮酸处理逆转了AOAA对胞质NAD/NADH比值的影响,这也恢复了LPS诱导的经AOAA处理的小胶质细胞的激活。此外,乳酸脱氢酶(LDH)抑制剂GSK2837808A阻断了丙酮酸对AOAA导致的胞质NAD/NADH比值降低和LPS诱导的小胶质细胞激活的影响。我们的研究还进一步表明,AOAA至少部分通过降低信号转导和转录激活因子3(STAT3)磷酸化来抑制LPS诱导的小胶质细胞激活。总的来说,我们的研究结果表明AOAA是一种抑制LPS诱导的神经炎症的新型有效药物。我们的研究还表明,MAS是LPS诱导的神经炎症的一种新型介质,因为它能够调节LPS诱导的STAT3磷酸化,这进一步突出了NAD/NADH代谢在炎症中的关键作用。